Bharat biotech's COVID-19 vaccine Covaxin gets DCGI nod for phase 3 clinical trial

The vaccine 'Covaxin' is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3koOCMj
via IFTTT